BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16985042)

  • 1. Mammographic density, hormone therapy, and risk of breast cancer.
    Ursin G; Pike M
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1750; author reply 1750. PubMed ID: 16985042
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pronounced differences in the estimation of breast cancer mortality in connection with hormone replacement therapy and mammographic screening].
    Jørgensen KJ
    Ugeskr Laeger; 2004 Apr; 166(15-16):1465. PubMed ID: 15146820
    [No Abstract]   [Full Text] [Related]  

  • 3. Menopausal hormone therapies: their effect on mammographic density and breast cancer risk.
    Santen R
    Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():12-6. PubMed ID: 16112950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term cessation of hormone replacement therapy and improvement of mammographic specificity.
    Harvey JA; Pinkerton JV; Herman CR
    J Natl Cancer Inst; 1997 Nov; 89(21):1623-5. PubMed ID: 9362162
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormone replacement therapy and high incidence of breast cancer between mammographic screens.
    Beral V; Banks E; Reeves G; Wallis M
    Lancet; 1997 Apr; 349(9058):1103-4. PubMed ID: 9107273
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
    Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is mammographic density, as currently measured, a robust surrogate marker for breast cancer?
    Yaffe M; Hendrix S; Pike M; Santen R; Eden J; Genazzani A
    Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():17-21. PubMed ID: 16112951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mammographic breast density and breast cancer risk during HRT].
    Bock K; Hadji P; Duda VF; Jackisch C; Wagner U
    Zentralbl Gynakol; 2005 Aug; 127(4):217-21. PubMed ID: 16037902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone therapy and breast cancer risk: trumping fear with facts.
    Kaunitz AM
    Menopause; 2006; 13(2):160-3. PubMed ID: 16645526
    [No Abstract]   [Full Text] [Related]  

  • 10. [Is estrogen therapy of significance for the incidence of breast cancer?].
    Bakken K
    Tidsskr Nor Laegeforen; 2004 Nov; 124(21):2801; author reply 2801. PubMed ID: 15534689
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormone replacement therapy and the breast.
    Dixon JM
    BMJ; 2001 Dec; 323(7326):1381-2. PubMed ID: 11744551
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Chu DZ
    J Natl Cancer Inst; 2008 Apr; 100(8):596-7. PubMed ID: 18398103
    [No Abstract]   [Full Text] [Related]  

  • 13. Mammographic density--a risk factor for breast cancer.
    Fait T; Zizka Z
    Prague Med Rep; 2007; 108(3):205-14. PubMed ID: 18399058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and mammographic density.
    Kilicdag EB; Bagis T; Pourbagher A; Tarim E
    Int J Gynaecol Obstet; 2004 Jul; 86(1):56-8. PubMed ID: 15207680
    [No Abstract]   [Full Text] [Related]  

  • 15. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Bliss JM; Gray R
    Lancet; 2003 Oct; 362(9392):1328-9; author reply 1330-1. PubMed ID: 14575984
    [No Abstract]   [Full Text] [Related]  

  • 16. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
    J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and the risk of breast cancer.
    Clemons M; Goss P
    N Engl J Med; 2001 Jan; 344(4):276-85. PubMed ID: 11172156
    [No Abstract]   [Full Text] [Related]  

  • 18. Breast cancer decline mirrors fall in hormone use, spurs both debate and research.
    McNeil C
    J Natl Cancer Inst; 2007 Feb; 99(4):266-7. PubMed ID: 17312300
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of hormone replacement therapy on mammographic findings.
    Bülbül NH; Ozden S; Dayicioglu V
    Arch Gynecol Obstet; 2003 Apr; 268(1):5-8. PubMed ID: 12673467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Breast density: a major parameter to follow during hormone replacement therapy].
    Gairard B; Guldenfels C; Haehnel P; Mathelin C
    Gynecol Obstet Fertil; 2009; 37(7-8):657-60. PubMed ID: 19577502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.